Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
allergan
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
glaxosmithkline
2
×
indiana blog main
indiana top stories
ipo
life sciences
medical devices
national
2
×
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
acceleron pharma
acid sphingomyelinase deficiency
alzheimer's disease
amgen
What
bio
roundup
august
biotech
black
busy
companies
continue
days
debut
decisions
devices
diamond
diamond’s
drugs
fda
indication
leading
legacy
life
mammoth
march
moves
news
nods
ohana’s
opioid
past
pop
regulatory
sarepta’s
science
seven
shkreli’s
slow
steady
street
stumble
suits
tends
Language
unset
2
×
Current search:
allergan
×
national
×
" raleigh-durham blog main "
×
unset
×
" new york blog main "
×
glaxosmithkline
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More